Valganciclovir - Simmaron Research

You are here: Simmaron Research Pathogens Viral Finding May Open Treatment Possibilities for 15-20K Chronic Fatigue Syndrome Patients in the U.S.Valganciclovir

Valganciclovir

August 1, 2013

Valganciclovir (Valcyte) is effective against HHV-6; (valaciyclovir) Valtrex is not

Print Friendly, PDF & Email

Twitter Facebook

Leave a Reply

@RedefiningMECFS Latest Tweets

RT @CornellMECFS: Recent ENID Center researcher and Hanson Lab grad, Dr. Alexandra Mandarano, presents her JCI manuscript published t… https://t.co/XeogLenAg2, 12 hours ago
RT @RedefiningMECFS: The Simmaron Research team is proud to have collaborated with @DrMaureenHanson on this project. Check out the previ… https://t.co/qtuYDXdYEu, Dec 13
The Simmaron Research team is proud to have collaborated with @DrMaureenHanson on this project. Check out the previ… https://t.co/qtuYDXdYEu, Dec 13

Follow @RedefiningMECFS

Copyright 2019 • Simmaron Research • Simmaron Research Inc. is a Non-Profit 501(c)(3)